---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-001365"
form_type: "8-K"
ticker: "TRVI"
cik: "0001563880"
company_name: "Trevi Therapeutics, Inc."
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:55:33.073690+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Trevi Therapeutics receives Nasdaq bid price deficiency notice; has until July 11, 2022 to regain compliance

## Summary
- Received deficiency letter from Nasdaq on Jan 10, 2022; bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until July 11, 2022) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may transfer to Nasdaq Capital Market for an additional 180-day compliance period, subject to other standards.
- May consider a reverse stock split or other measures to cure; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001564590-22-001365
- form_type: 8-K
- ticker: TRVI
- cik: 0001563880
- company_name: Trevi Therapeutics, Inc.
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563880/000156459022001365/0001564590-22-001365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563880/000156459022001365/trvi-8k_20220110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-001365
- JSON: https://secwatch.observer/filing/0001564590-22-001365.json
- Plain text: https://secwatch.observer/filing/0001564590-22-001365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.